PAVmed (PAVM) FCF Margin (2021 - 2025)

PAVmed has reported FCF Margin for 5 years, with the latest figure at 1876.54% in Q4 2025.

• On a quarterly basis, FCF Margin fell 277654.0% year-over-year to 1876.54% in Q4 2025; TTM through Dec 2025 was 5237.0%, a 403041.0% decrease from a year earlier, with the FY2025 full-year figure at 5237.0%, down 411483.0% from the prior year.
• FCF Margin was 1876.54% for Q4 2025 at PAVmed, up from 18880.0% in the prior quarter.
• The five-year high for FCF Margin was 900.0% in Q4 2024, with the low at 25864.47% in Q3 2022.
• Average FCF Margin over 5 years is 8359.78%, with a median of 5022.25% recorded in 2021.
• The sharpest annual moves came in 2022 and 2023: FCF Margin tumbled 2183797 bps in 2022, then surged 2446030 bps in 2023.
• Over 5 years, FCF Margin stood at 6018.0% in 2021, then slumped by 154 bps to 15286.61% in 2022, then soared by 92 bps to 1149.38% in 2023, then soared by 178 bps to 900.0% in 2024, then sank by 309 bps to 1876.54% in 2025.
• The last three FCF Margin figures came in at 1876.54% (Q4 2025), 18880.0% (Q3 2025), and 19450.0% (Q2 2025), per Business Quant data.